On March 2, 2026, GSK plc announced the purchase of 500,000 ordinary shares as part of its buyback program, with prices ranging from 2,168.00p to 2,195.00p per share. This brings the total shares purchased since February 17, 2026, to 4,636,000, holding 244,527,094 shares in treasury.